Literature DB >> 24198884

Neurological sequelae in survivors of cerebral malaria.

Isaac Oludare Oluwayemi1, Biobele Joackim Brown, Olusola Adetunji Oyedeji, Margaret Adefiola Oluwayemi.   

Abstract

INTRODUCTION: Cerebral malaria is a common cause of neurological sequelae and death in childhood. Information on persistent neurological sequelae post hospital discharge and their predisposing factors are scarce.
METHODS: This is a prospective study describing persisting neurological impairments post discharge among children treated for cerebral malaria. In addition the study was designed to investigate the frequency of persistent neurologic deficits and the risk factors for their persistence in these patients. The case records of 160 patients treated for CM at the Paediatrics Department of University College Hospital, Ibadan from January 2004 to November 2006 were reviewed to recruit cases. Recruited survivors were then followed up for information concerning the presence and persistence of neurological sequelae.
RESULTS: A total of 160 children aged 9 months to 134 months were admitted and treated for CM during the study period. One hundred and thirty one (81.9%) survived while 29 (18.1%) died. The 131 survivors of cerebral malaria consisted of 64 boys and 67 girls. Neurological sequelae occurred in 13.7% of survivors of cerebral malaria at discharge and 4.6% at follow up. Six children with neurological deficits at discharge had persistence of deficits 6 months post-hospital discharge and one at 24 months. No associations were found between hypoglycemia, anemia, age, sex and multiplicity of convulsions, and persistence of neurologic sequelae. The persisting neurologic deficits among survivors at follow up were: memory impairment (1.5%), seizure disorders (0.8%), visual impairment (0.8%), speech impairment (0.8%), monoparesis (0.8%) and hyperactivity (0.8%) at follow up. The longest persisting sequelae lasted for at least 24 months.
CONCLUSION: Neurologic deficits are not uncommon complications of CM. Neurologic sequelae may persist for as long as 24 months or more in survivors of childhood CM. There is no association between the risk factors for neurologic deficits and persistent neurologic sequelae.

Entities:  

Keywords:  Cerebral malaria; Nigeria; children; neurological sequelae

Mesh:

Year:  2013        PMID: 24198884      PMCID: PMC3810154          DOI: 10.11604/pamj.2013.15.88.1897

Source DB:  PubMed          Journal:  Pan Afr Med J


Introduction

Plasmodium falciparum is the most common cause of malaria worldwide [1]. It is responsible for almost all the mortality from malaria and affects the central nervous system causing neurological deficits and cognitive sequelae [1-3]. The social and economic burden of malaria in malaria-endemic countries is immense [4]. Cerebral malaria is the most severe neurological presentation of acute falciparum malaria, the clinical hallmark of which is the presence of coma [3]. It is a diffuse encephalopathy associated with seizures in at least 80% and status epilepticus, in up to a third of cases [5-7]. Multiple or prolonged seizures in cerebral malaria have been reported to be associated with epilepsy later in life [8-10]. The case fatality rate of cerebral malaria ranges between 5 and 50 percent [5]. Although most survivors make a full recovery, neurological sequelae such as hemiplegia, speech problems, cortical blindness and epilepsy occur in 3-31 percent [6, 8, 9] Despite the growing recognition that Plasmodium falciparum malaria significantly threatens child survival and long-term impairment of cognition often follows early insult and injury to growing brains, inadequate attention has been given to the impact of malaria on general cognitive and behavioural development of children after discharge from the hospital by previous reports [9, 11]. Most of the previous studies report neurological sequelae in the acute phase or at discharge from the hospital in cerebral malaria [5, 12–14]. There are very few reports on the long term neurological sequelae in survivors of childhood cerebral malaria [8, 9, 11]. This study therefore focuses on describing persisting neurological impairments among children treated for cerebral malaria after a period of at least six months from the time of diagnosis. The study was carried out at the Paediatric Department of the University College Hospital, Ibadan, Nigeria and the homes of the patients in Ibadan community.

Methods

The present study is a cross sectional study. The subjects were children who were previously admitted and treated for cerebral malaria at least six months before the time of study, who were then followed up for presence or persistence of neurological sequelae. Ethical clearance was obtained from The Joint University of Ibadan and University College Hospital Ibadan Ethical Committee. Informed verbal consent was obtained from the parents or guardians of the children and explanation was made to the children as much as possible to ensure their optimal cooperation. All children with cerebral malaria admitted into Children Emergency ward between January 2004 and November 2006 were identified from admission records book and their case record files were retrieved from the Records Department of the University College Hospital. Baseline demographic and clinical data of patients at the time of diagnosis of cerebral malaria was extracted from the case notes using a structured case record form. The homes of affected patients were traced, using the contact addresses and mobile phone numbers in the case records. Enquiries were made to exclude other causes of brain injury between discharge and time of review. During the home visit, information was obtained from the caregivers. General clinical and detailed neurological examination (motor, gait, vision, speech, hearing, other cranial nerves, and intelligence quotient assessment) was carried out on the survivors of cerebral malaria and the information obtained was recorded in a structured case record form. Children with neurological deficits needing further evaluation were comprehensively reviewed at University College Hospital, Ibadan by specialists such as the ophthalmologist and physiotherapist in order to determine the exact deficit and its extent with the view of managing appropriately. Data was analyzed using SPSS 11.0 for Windows (SPSS Inc., Chicago, USA). The patients were grouped based on age and the presence or absence of neurological deficit. Data was presented as frequency tables and mean ± standard deviations (x ± SD). Selected clinical and laboratory factors such as duration of coma, nutritional status, multiple seizures, anaemia and hypoglycemia were compared in those with and without sequelae. Analysis for significance was by use of Chi square or Fishers exact test, where counts were less than 5. P values less than 0.05 was regarded as significant. Neurologic sequelae were defined as impairment of neurologic or cognitive function. Specifically they include: impairment or loss of function in musculoskeletal system, these includes paralysis or paresis manifesting as inability to walk, staggering, monoparesis, hemiparesis, quadriparesis; memory impairment (unusual forgetfulness of recent events), hyperactivity (excessive activity on the part of the child), seizure disorder (two or more seizures after discharge from hospital, unprovoked by fever), speech Impairment (difficulty in verbal expression), hearing impairment (inability to hear, or turn toward sound), and visual impairment (inability to visually follow brightly coloured objects or pick such objects with open eyes) [2].

Results

General characteristics of the study patients

A total of 160 patients aged 9 months to 134 months were admitted with diagnosis of cerebral malaria during the study period; 131 (81.9%) survived while 29 (18.1%) died. Of the 131 survivors of cerebral malaria, 18 (13.7%) had neurological deficits at discharge. Four of the 18 survivors with neurological deficits at discharge were lost to follow up in the community while 6 (4.6%) survivors had persisting neurological sequelae for more than 6 months after discharge from the hospital.

Age and sex distribution

The 131 survivors were made up of 64 males and 67 females giving a male to female ratio (M:F) of 1:1.05. The age distribution of survivors shown in Table 1 reveals increasing frequency from infancy with a peak in the 36 - 47 months age group. The majority (71.8%) of children were under 5 years of age.
Table 1

Age distribution of survivors of cerebral malaria

Age groups (months)Number of cases
6 – 114
12 – 2319
24 – 3525
36 – 4730
46 – 5917
60 – 7117
72 – 834
84 – 955
96 – 1075
108 – 1192
120 – 1312
132 – 1431
Age distribution of survivors of cerebral malaria

Duration of follow up and Frequency of neurological sequelae in survivors of CM

The survivors were followed up for a period that ranged from 6 months to 33 months with a median duration of 17.5 months from discharge to follow up. Eighteen (13.7 percent) of 131 survivors had neurological deficit(s) at discharge. Four of these were lost to follow up, giving an attrition rate of 22.2 percent among patients with neurologic deficit. Of the 131 survivors 6 had persisting neurological sequelae at 6 months, constituting 4.6 percent of all survivors and 33.3 percent of the 18 survivors with neurologic deficits at discharge. Thirty-eight neurologic deficits were identified among the 18 children at discharge. Of these thirty-eight deficits, 22 (57.9%) resolved completely while 9 (23.7%) persisted among 6 children. At follow-up, the most common persisting neurological deficit was memory impairment observed in 2 cases (Table 2). All the visual impairment resolved completely except a case later diagnosed as mild bilateral optic atrophy. The longest persisting neurologic sequela was a case of memory impairment lasting 24 months. Seven (18.4%) deficits in the 4 cases lost to follow up could not be reviewed (Table 3).
Table 2

Prevalence of neurologic deficits among survivors

Neurological DeficitDeficit present at DischargeDeficit at follow up
n% of all survivors at discharge (N = 131)n% of all survivors (N = 131)
Visual Impairment53.810.8
Speech Impairment107.610.8
Memory Impairment53.821.5
Seizure Disorder10.810.8
Movement Disorder96.9-0.0
Monoparesis21.510.8
Quadriparesis10.810.8
Hyperactivity32.310.8
Hemiparesis10.8N/AN/A
Hearing impairment10.8N/AN/A

N/A = Not available (lost to follow up)

Table 3

Pattern of neurologic deficit in survivors of cerebral malaria

Age at Diagnosis (months)SexNeurological DeficitsDuration between discharge &review (months)
At DischargeAt Follow up
60FSpeech impairment, Movement disorderNormal24
60MMovement disorder, speech impairment, memory impairmentNormal33
62FRight upper limb monoparesis, Speech impairment, memory impairmentRight upper limb monoparesis12
22FMovement disorderNormal33
72FMovement disorderNormal26
84FMovement disorder, speech disorder, memory impairmentNormal28
99MRight lower limb monoparesisNormal17
78MMemory impairmentMemory impairment24
43FHyperactivityNormal14
36MVisual impairment, speech impairment, movement disorderMild optic atrophy6
46MMovement disorder, speech impairmentNormal6
48FHyperactivity, visual impairment, speech disorder, memory impairmentMemory impairment, hyperactivity18
36MVisual impairment, hyperactivity, movement disorderHyperactivity, memory impairment12
27MSeizure disorder, quadriparesis, speech impairmentCerebral palsy with seizure disorder, spastic quadriparesis, speech impairment8
47MSpeech impairment, visual impairment, hearing impairmentLost to follow up
31FHemiparesisLost to follow up
40FSpeech impairmentLost to follow up
11MMovement disorder, Visual impairmentLost to follow up
Prevalence of neurologic deficits among survivors N/A = Not available (lost to follow up) Pattern of neurologic deficit in survivors of cerebral malaria

Pattern of neurological sequelae in CM survivors

The 18 children with neurologic impairment at discharge had 38 neurologic deficits. The commonest neurological deficits at discharge were movement disorder and speech impairment in 9 children each, followed by visual impairment and memory impairment in 5 children each. Seizure disorder, hearing impairment, hemiparesis and quadriparesis occurred in one child each.

Potential risk factors for neurological deficit in CM

No significant association was found between selected factors such as hypoglycaemia, severe anaemia, multiple seizures, under-nutrition, age, duration of coma among those with or without neurologic deficits at follow up. This result is shown in Table 4.
Table 4

Associations between selected factors and neurologic deficits at follow up

Selected factorNeurologic deficit at follow upX2 P
PresentAbsent
Hypoglycaemia (<2.2 mmol/L)
 Yes00-1.00
 No633
Anaemia (haematocrit ≤5g/dl)
 Yes020.380.71
 No631
Multiple seizures
 Yes5153.750.06
 No118
Undernutrition
 Yes190.300.51
 No524
Age (<5years)
 Yes4230.020.61
 No210
Duration of coma ≥ 2days
 Yes241.750.22
 No429
Sex
 Male4141.200.39
 Female219
Associations between selected factors and neurologic deficits at follow up

Discussion

Neurological impairment following CM is not uncommon and a number of studies have documented these [2, 6, 8–11, 15, 16]. The 13.7% neurological deficit prevalence in this study compares slightly lower to 17.7% and 15% documented by Bondi and Olumese et al respectively in the same centre some 30 and 25 years previously [8, 12]. The difference may be due to the different sample size and age groups of studied survivors. Also, the improvement in treatment modalities of CM over the past 25-30 years could explain the reduction in neurologic deficit estimates. The prevalence of persisting neurological deficits in survivors of cerebral malaria in this study was 4.6%. This is an improvement over 9.7% prevalence reported by Bondi in the same centre 30 years earlier but higher than 2.6% prevalence obtained by Meremikwu et al in Calabar, Nigeria [8, 15]. The improvement in the prevalence of persisting neurological sequelae among survivors of cerebral malaria in the same centre over 3 decades could probably be due to improved case management of CM. The persisting neurological deficits in this study were memory impairment, visual impairment, speech impairment, monoparesis, quadriparesis and hyperactivity. There was no persisting case of movement disorder which was the second commonest neurological deficit at discharge. Memory impairment was the most common persisting sequelae in this study. It usually becomes more obvious as survivors advance in age and face academic challenges. Our findings in the present study are similar to those of Cater et al at Kenya [16]. Subtle neuro-cognitive deficits, like memory impairment may be missed at discharge. This might find expression in later life when the survivors’ cognitive task increases in complexity [16]. Thus it is very important that survivors of cerebral malaria are well evaluated. Management should also be multidisciplinary with input from physiotherapists, special educationists, professionals or community rehabilitative workers, as the case may demand, in order to allow survivors to attain their maximum potential. This will also help protect these children from undue stress, neglect and abuse. Neurologically impaired survivors are prone to reduced opportunities in education, marriage, and employment. The persisting neurological deficits found in this study, such as; ataxia, motor deficits, hearing impairment, visual impairment, speech difficulties, behavior difficulties, severe learning difficulties, seizure disorder, hemiplegia, spastic quadriplegia and cognitive impairment are very similar, with few exceptions, to those described in previous studies [2, 6, 8–11, 15, 16]. Visual impairment due to cortical blindness resulting from cerebral malaria usually resolve completely within 8 weeks of regaining consciousness [8, 13, 15, 17]. Diagnosis of the persisting case of visual impairment in this study as bilateral optic atrophy by the ophthalmologist underscores the need for multidisciplinary management. The prevalence of seizure disorder in this study was 0.8%. This is higher than 0.2% reported by van Hensbroek et al in a study of 452 Gambian children who survived cerebral malaria [10]. It is however lower than the prevalence of 1.6% reported by Bondi thirty years earlier in the same center.8 Differences in clinical settings and geographical locations and improvement in the standard of care of CM may probably account for the variance in prevalence over time. Crawley et al in the study of 65 Kenyan children with cerebral malaria documented 1.5% prevalence of seizure disorder among survivors [7]. Different types of seizures including partial motor, generalized tonic'clonic and partial with secondary generalization were described during admission but post-cerebral malaria seizure disorders were poorly documented. The only persistent seizure disorder in this study was generalized tonic-clonic. A third of the survivors who had neurological deficit at discharge in this study continued to have deficit at follow-up. This is comparable to 34.4% reported by Brewster et al in The Gambia and 38% in Kenya by Carter et al but lower than 54.5% reported by Bondi in the same centre 30 years ago [6, 8, 9]. The reduction in the proportion of survivors who continued to have neurological deficit at discharge in the same centre over the space of 30years has been previously attributed to improved standard of health and case management which is commendable. The difference could also be due to a longer duration between discharge and follow up assessment in this study (6 - 33 months) compared to 12 - 16 months in the earlier study by Bondi [8]. There was no statistically significant association between selected factors such as hypoglycaemia, severe anaemia, multiple seizures, under-nutrition, age, duration of coma and the presence or absence of neurologic deficits at follow up. These are at variance to the commonly reported findings in other studies [8, 12, 17]. This disparity may be due to a high index of suspicion and aggressive resuscitation of all unconscious children in our emergency room presently which might nullify the risks posed by such factors like anaemia, hypoglycaemia, prolonged coma and multiple seizures. A steady rise in the cases of CM survivors was recorded in the first four years of life. Most of these children were aged between 36 - 47 months. About three-quarters of the survivors of cerebral malaria during the 3 years study period were under 5 years of age. This is consistent with previous studies reporting that the most vulnerable age groups are the under-five children [7, 8, 14, 18].

Conclusion

It is concluded that, the present study shows that neurological sequelae is common among survivors of CM. A minority have neurological deficits persisting beyond 6 months with memory impairment being the most common. The most vulnerable age groups were the under-five.
  17 in total

1.  Economic burden of malaria illness on households versus that of all other illness episodes: a study in five malaria holo-endemic Nigerian communities.

Authors:  O Onwujekwe; R Chima; P Okonkwo
Journal:  Health Policy       Date:  2000-11-17       Impact factor: 2.980

Review 2.  The burden of the neurocognitive impairment associated with Plasmodium falciparum malaria in sub-saharan Africa.

Authors:  Victor Mung'Ala-Odera; Robert W Snow; Charles R J C Newton
Journal:  Am J Trop Med Hyg       Date:  2004-08       Impact factor: 2.345

3.  The incidence and outcome of neurological abnormalities in childhood cerebral malaria: a long-term follow-up of 62 survivors.

Authors:  F S Bondi
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Jan-Feb       Impact factor: 2.184

Review 4.  Impact of Plasmodium falciparum malaria on performance and learning: review of the evidence.

Authors:  P A Holding; R W Snow
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

5.  Increasing burden of childhood severe malaria in a Nigerian tertiary hospital: implication for control.

Authors:  Adebola Emmanuel Orimadegun; Olufunmi Fawole; James Okorie Okereke; Felix Olukayode Akinbami; Olugbemiro Sodeinde
Journal:  J Trop Pediatr       Date:  2007-02-07       Impact factor: 1.165

6.  Increased prevalence of epilepsy associated with severe falciparum malaria in children.

Authors:  Julie A Carter; Brian G R Neville; Steven White; Amanda J Ross; Godfrey Otieno; Neema Mturi; Cris Musumba; Charles R J C Newton
Journal:  Epilepsia       Date:  2004-08       Impact factor: 5.864

Review 7.  Evolutionary and historical aspects of the burden of malaria.

Authors:  Richard Carter; Kamini N Mendis
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

8.  Neurological features of cerebral malaria in Nigerian children.

Authors:  P E Olumese; R A Gbadegesin; A A Adeyemo; B Brown; A Walker
Journal:  Ann Trop Paediatr       Date:  1999-12

9.  Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children.

Authors:  M E Molyneux; T E Taylor; J J Wirima; A Borgstein
Journal:  Q J Med       Date:  1989-05

Review 10.  Neurological sequelae of cerebral malaria in children.

Authors:  D R Brewster; D Kwiatkowski; N J White
Journal:  Lancet       Date:  1990-10-27       Impact factor: 79.321

View more
  11 in total

1.  NADPH Oxidase: a Possible Therapeutic Target for Cognitive Impairment in Experimental Cerebral Malaria.

Authors:  Simhadri Praveen Kumar; Phanithi Prakash Babu
Journal:  Mol Neurobiol       Date:  2021-11-16       Impact factor: 5.682

Review 2.  Cerebral malaria--clinical manifestations and pathogenesis.

Authors:  Rachna Hora; Payal Kapoor; Kirandeep Kaur Thind; Prakash Chandra Mishra
Journal:  Metab Brain Dis       Date:  2016-01-08       Impact factor: 3.584

3.  Clinical features and haematological parameters among malaria patients in Mangaluru city area in the southwestern coastal region of India.

Authors:  Kishore Punnath; Kiran K Dayanand; Valleesha N Chandrashekar; Rajeshwara N Achur; Srinivas B Kakkilaya; Susanta K Ghosh; Benudhar Mukhi; Vishal Midya; Suchetha N Kumari; D Channe Gowda
Journal:  Parasitol Res       Date:  2019-11-21       Impact factor: 2.289

4.  Epidemiology of Acute Symptomatic Seizures among Adult Medical Admissions.

Authors:  Paul Osemeke Nwani; Maduaburochukwu Cosmas Nwosu; Monica Nonyelum Nwosu
Journal:  Epilepsy Res Treat       Date:  2016-01-24

Review 5.  Pathophysiology and neurologic sequelae of cerebral malaria.

Authors:  Nicoline Schiess; Andres Villabona-Rueda; Karissa E Cottier; Katherine Huether; James Chipeta; Monique F Stins
Journal:  Malar J       Date:  2020-07-23       Impact factor: 2.979

6.  Euterpe oleracea fruit (Açai)-enriched diet suppresses the development of experimental cerebral malaria induced by Plasmodium berghei (ANKA) infection.

Authors:  Karen Renata Herculano Matos Oliveira; Marjorie Lujan Marques Torres; Nayara Kauffmann; Brenda Jaqueline de Azevedo Ataíde; Nívia de Souza Franco Mendes; Larissa Medeiros Dos Anjos; Rosivaldo Dos Santos Borges; Carlomagno Pacheco Bahia; Luana Ketlen Reis Leão; Adelaide da Conceição Fonseca Passos; Anderson Manoel Herculano; Evander de Jesus Oliveira Batista
Journal:  BMC Complement Med Ther       Date:  2022-01-11

7.  Delayed presentation to hospital care is associated with sequelae but not mortality in children with cerebral malaria in Malawi.

Authors:  Arabella Borgstein; Bo Zhang; Colin Lam; Montfort Bernard Gushu; Alice Wangui Liomba; Albert Malenga; Paul Pensulo; Andrew Tebulo; Dylan S Small; Terrie Taylor; Karl Seydel
Journal:  Malar J       Date:  2022-02-22       Impact factor: 2.979

Review 8.  Malaria Related Neurocognitive Deficits and Behavioral Alterations.

Authors:  Pamela Rosa-Gonçalves; Flávia Lima Ribeiro-Gomes; Cláudio Tadeu Daniel-Ribeiro
Journal:  Front Cell Infect Microbiol       Date:  2022-02-22       Impact factor: 5.293

Review 9.  Cerebral malaria induced by plasmodium falciparum: clinical features, pathogenesis, diagnosis, and treatment.

Authors:  Xiaonan Song; Wei Wei; Weijia Cheng; Huiyin Zhu; Wei Wang; Haifeng Dong; Jian Li
Journal:  Front Cell Infect Microbiol       Date:  2022-07-25       Impact factor: 6.073

Review 10.  Sphingosine 1-Phosphate in Malaria Pathogenesis and Its Implication in Therapeutic Opportunities.

Authors:  Gunanidhi Dhangadamajhi; Shailja Singh
Journal:  Front Cell Infect Microbiol       Date:  2020-08-14       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.